Ignite Creation Date:
2024-05-06 @ 10:08 AM
Last Modification Date:
2024-10-26 @ 12:25 PM
Study NCT ID:
NCT03177330
Status:
UNKNOWN
Last Update Posted:
2017-06-06
First Post:
2017-06-04
Brief Title:
Safety and Efficacy of Heparin Dosing Score Protocol for Polymyxin-B Hemoperfusion
Sponsor:
National Taiwan University Hospital
Organization:
National Taiwan University Hospital
Study Overview
Official Title:
Safety and Efficacy of Heparin Dosing Score Protocol for Anticoagulation During Polymyxin-B Hemoperfusion a Retrospective Study
Status:
UNKNOWN
Status Verified Date:
2017-06
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Polymyxin B hemoperfusion PMX-HP is mainly used to remove endotoxins in septic shock patients with intra-abdominal infections Because of the concerns of postoperative bleeding physicians may hesitate to use anticoagulation in patients with septic shock within a few hours after an abdominal operation We developed a heparin dosing score protocol for heparin dosage adjustment The purpose of the study is to examine the safety and efficacy of the heparin dosing score protocol
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None